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Abstract 
Objective: Frailty is a syndrome of reduced resistance to respond to stressors, causing 
increased vulnerability to adverse outcomes. Associations between frailty and 
cognitive impairment in non-psychiatric elderly have been found, however this 
association is unclear for psychiatric elderly patients. The aim of this study was to 
examine the prevalence of frailty, gender and Diagnostic and Statistical Manual of 
Mental Disorders (DSM-5) differences in this prevalence, and the relationship 
between cognitive impairment and frailty in elderly with psychiatric disorders. 
Methods: We conducted a cross-sectional study with 50 patients of 65 years and 
older, hospitalized at a Dutch psychiatric institution. If three of the Fried criteria were 
present (weight loss, weakness, exhaustion, slowness, and low physical activity), a 
patient was considered frail. Cognitive functioning was assessed by the Mini Mental 
State Examination and the clock drawing test. Multiple logistic regressions, adjusted 
for age and gender, were performed to examine the association between cognitive 
impairment and frailty.   
 Results: The frailty prevalence was 36.0%, we found no gender differences or 
differences in DSM-5 diagnosis concerning this prevalence. The prevalence of the co-
occurrence of frailty and cognitive impairment was 16.7%. Cognitive impairment 
predicted frailty (OR=5.45 p= .019), as well as two components of frailty: weakness 
(OR = 8.89 p = .012) and slowness (OR=6.81 p= .020). The regression analyses were 
significant before and after correction for age and gender.  
Conclusion: Both frailty and the co-occurrence of frailty and cognitive impairment 
are highly prevalent in psychiatric elderly patients. There is a strong association 
between the two syndromes, therefore therapists should be aware of the higher chance 
of a cognitively impaired patient to also be frail. Future research is needed to examine 
the interrelationship, underlying mechanisms, cognitive domains, and interventions in 
this population. 
 
 
 
3 
 
Introduction 
 
According to the World Health Organization (WHO; 2015) the elderly 
population of the world is expected to increase from 900 million in 2015 to two 
billion in 2050. This rapid increase is, among other things, due to the extension of life 
expectancy (WHO, 2015). As a result of this ageing of the world’s population, the 
number of people with disabilities and chronic health conditions is increasing. Caring 
for dependent elderly is a costly challenge for modern healthcare (Robertson, Savva, 
& Kenny, 2013). This is one of many reasons to further examine this group, as better 
understanding of elderly could lead to new evidence-based interventions and 
consequently to the reduction in healthcare costs. However, not every elderly of the 
same chronological age has the same risk to experience health problems and 
becoming dependent upon help from others. One 70-year-old can be completely 
healthy, while the other 70-year-old can experience various health problems. The 
concept of frailty tries to explain this difference of adverse health outcomes among 
elderly of the same chronological age (Theou et al., 2015).   
Frailty is a common, heterogeneous biologic syndrome of reduced physiologic 
reserve and resistance to respond to external stressors, causing increased vulnerability 
to adverse outcomes (e.g., disability, falls, hospitalization, institutionalization, and 
mortality; Fried et al., 2001; Langlois et al., 2012). Frailty is recognized to be a 
distinct clinical syndrome that is separated from, although associated with, ageing, 
comorbidity, disability, and chronic diseases (Houles et al., 2012). The most widely 
used operationalization of frailty is the physical frailty phenotype of Fried et al. 
(2001). This phenotype of frailty is classified if three or more of the following criteria 
are present: unintentional weight loss, weakness, exhaustion, slowed gait, and low 
physical activity level (Fried et al., 2001). The prevalence of frailty increases with 
age, as shown in the Canadian Study of Health and Aging where a frailty prevalence 
of 7.0% was found for elderly aged 65-74, 17.5% for elderly aged 75-84, and 36.6% 
for elderly aged 85+ (Rockwood et al., 2004). A higher prevalence has been found in 
women, they have almost twice as much chance to be frail compared to men. (Fried et 
al., 2001; Rockwood et al., 2004). Alongside the physical complaints, cognitive 
impairment has been suggested as an additional factor present in frail elderly 
(Langlois et al., 2012).  
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Frailty and cognitive impairment are two common syndromes in elderly 
people (Morley, 2015). The association between these two syndromes in elderly 
received considerable attention, and has been found in both cross-sectional (Ávila-
Funes et al., 2009; Jurschik et al., 2012; Macuco et al., 2012) and longitudinal studies 
(Ávila-Funes et al., 2012; Samper-Ternent, Al Snih, Raji, Markides, & Ottenbacher, 
2008; Solfrizzi et al., 2013). The cross-sectional studies have shown a strong 
correlation between cognitive impairment and frailty. Compared to non-frail elderly, 
frail elderly have significant higher rates of cognitive impairment (Robertson et al., 
2013). This correlation was not explained by demographic variables or the number of 
chronic diseases (Buchman et al., 2014). In the relation between cognitive impairment 
and frailty, age is an effect modifier, meaning that the oldest elderly showed a 
stronger correlation than younger elderly (Assis Faria, Lourenco, Ribeiro, & Lopes, 
2013). Of the different components of frailty, the highest correlations with cognitive 
impairment have been found with weakness and slowed gait speed (Robertson, Savva, 
Coen, & Kenny, 2014). Alongside the correlational research, other studies have 
analyzed the predictive values of cognition and frailty (Jacobs, Cohen, Ein-mor, 
Maaravi, & Stessman, 2011; Han, Lee, & Kim, 2014; Ottenbacher et al., 2005). It is 
assumed that cognitive impairment precedes frailty and vice versa (Auyeung, Lee, 
Kwok, & Woo, 2011). For instance, impairment in executive functioning, a cognitive 
domain, can lead to slowed gait speed, a frailty component (Robertson et al., 2013). 
Han et al. (2014) conducted a cross-sectional study with cognitive impairment, 
measured by the Mini Mental State Examination (MMSE), as a predictor of physical 
frailty, measured by the Fried et al. (2001) criteria. They found that cognitively 
impaired participants were almost twice as likely to be frail than cognitively intact 
participants.  
 In contrast to the association between frailty and cognitive impairment, the 
prevalence of the co-occurrence of frailty and cognitive impairment has received less 
attention. To our knowledge, only Shimada et al. (2013) examined this, and found a 
prevalence of the co-occurrence of 2.7% in a Japanese sample. Examining the 
prevalence of the co-occurrence of frailty and cognitive impairment is important 
because elderly who are both frail and cognitively impaired, may be at higher risk of 
functional decline (Shimada et al., 2013). Replication in a Western sample will make 
conclusions and implications easier to generalize for Western patients.  
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Longitudinal studies have shown that the presence of frailty leads to higher 
risk of cognitive decline, mild cognitive impairment, vascular dementia, and 
Alzheimer’s dementia (Ávila-Funes et al., 2012; Samper-Ternent et al., 2008; 
Solfrizzi et al., 2013). However, cognitive impairment also increased the risk of 
frailty, which suggests an interrelationship between cognition and frailty (Robertson 
et al., 2013). Multiple possible underlying mechanisms have been suggested to 
explain this relationship. The first mechanism is neuropathological. Buchman, 
Schneider, Leurgans, & Bennett (2008) found that Alzheimer’s pathology, e.g., 
neurofibrillary tangles and amyloid plaques, was associated with increased levels of 
frailty. The second mechanism is a chronic inflammatory reaction. Stress reactions, 
chronic diseases, lifestyle factors, and other factors can generate an inflammatory 
response, e.g., increased pro-inflammatory cytokines, interleukin-1, and tumor 
necrosis factor (Robertson et al., 2013). With ageing, levels of interleukin-6 can 
increase. These inflammatory reactions can lead to reduced body mass, weakened 
muscles, and poorer physical performance; consequently leading to frailty (Kang et 
al., 2016). Additionally, these inflammatory reactions can lead to neurotoxicity; 
consequently causing cognitive impairment (Kang et al., 2016; Robertson et al., 
2013). The third mechanism is hormonal. Testosterone has a protective effect on 
cognition. Consequently, reduced testosterone may lead to cognitive decline 
(Robertson et al., 2013). Additionally, reduced testosterone is also associated with 
weakened muscles, which is one of the frailty criteria (Robertson et al., 2013). 
Reduced insulin is associated with an increased risk for both cognitive impairment 
and frailty (Robertson et al., 2013). The fourth mechanism is cardiovascular risk. 
Cardiovascular disease has been found to be associated with frailty. Like 
inflammatory reactions, cardiovascular disease can lead to weakened muscles 
(Robertson et al., 2013). Additionally, vascular risk factors can lead to cognitive 
impairment and dementia (Robertson et al., 2013). The fifth mechanism is nutritional. 
Cognitively impaired elderly may not be able to adequately regulate their nutritional 
intake, which can lead to reduced body mass and weakened muscles; possibly leading 
to frailty (Kang et al., 2016). Additionally, elderly with sarcopenia (the loss of muscle 
mass and strength, associated to ageing) are at increased risk to develop cognitive 
impairment (Kang et al., 2016). The last mechanism is mental health. Mood disorders, 
as depression, have an amplifying influence on the relationship between frailty and 
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cognitive impairment. Depression can affect cognitive functions, but is also both a 
risk factor and outcome of frailty (Robertson et al., 2013).  
Although a considerable amount of studies have examined frailty, the majority 
of the existing literature has focused on samples consisting of community dwelling 
elderly (e.g., Ávila-Funes et al., 2008; Clegg, Rogers, & Young, 2014; Theou et al., 
2015). Frailty in elderly with Diagnostic and Statistical Manual of Mental Disorders 
(DSM-5) disorders has received relatively little attention. However, frailty is an 
important concept in old age psychiatry, because of the overlap between frailty and 
psychiatric disorders (e.g., cognitive impairment, depression). Furthermore, early 
detecting of frailty in elderly psychiatric patients could help to adjust the psychiatric 
treatment and may lead to effective interventions that could prevent or delay the 
adverse health outcomes of frailty. In research with non-psychiatric elderly this has 
already led to evidence-based interventions, like following an adequate diet and 
physiotherapy, which target two frailty components (Collard & Oude Voshaar, 2012). 
Frailty is strongly associated with healthcare costs, and interventions improving frailty 
could lead to a reduction in these costs (Butler et al., 2016). A better understanding of 
the association between frailty and cognitive impairment in elderly with psychiatric 
disorders may also lead to effective interventions and possible costs reductions.  
The first aim of this study was to describe the prevalence of frailty in our 
sample of psychiatric elderly patients, and its association with gender and DSM-5 
diagnosis, using the following research questions: 
1.1 What is the prevalence of frailty in elderly with psychiatric disorders? 
1.2 Are there gender differences in the prevalence of frailty?  
It was hypothesized that a higher prevalence would be found in women, 
compared to men.  
1.3 Are there differences in the prevalence of frailty between the DSM-5 diagnosis 
groups?  
As far as we are aware, the differences per DSM-5 diagnosis group have never 
been researched in existing frailty studies. Therefore, we will explore these 
differences, using three diagnosis groups: depressive disorders, bipolar 
disorders, and psychotic disorders. 
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The second aim was to examine the association between frailty and cognitive 
impairment in our sample, using the following research questions: 
2.1 What is the prevalence of the co-occurrence of frailty and cognitive 
 impairment? 
2.2 Is cognitive impairment a significant predictor of frailty? 
 It was hypothesized that cognitive impairment is a significant predictor of 
 frailty.  
2.3 Is cognitive impairment a significant predictor of weakness? 
It was hypothesized that cognitive impairment is a significant predictor of 
weakness. 
2.4 Is cognitive impairment a significant predictor of slowness?  
It was hypothesized that cognitive impairment is a significant predictor of 
slowness. 
Research has shown that age and gender may affect frailty, and the relation between 
frailty and cognitive impairment, therefore these variables were included as covariates 
(Assis-Faria et al., 2013; Fried et al., 2001; Rockwood et al., 2004).  
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Methods 
 
Design  
 We conducted a cross-sectional study in a sample of elderly people with 
psychiatric disorders, which was part of a longitudinal study. The data-collection of 
the cross-sectional study started in February 2017 and ended in May 2017. The 
current study was based on baseline data and data of a pilot study. The pilot study was 
conducted in 2016 and comprised 12 patients. The measurements of the pilot study 
overlapped those of the current study, but the current study included a few extra 
measurements.  
 
Participants 
 Patients of 65 years and older with a DSM-5 disorder, who were hospitalized 
at the old age psychiatry department of Parnassia Group in The Hague, the 
Netherlands, were suitable for inclusion. Patients were excluded if they were non-
fluent in Dutch, had a diagnosis of dementia, or refused participation. A few patients 
(n=3) were untestable due to the severity of their psychiatric condition and therefore 
excluded. Six patients were already discharged from hospitalization before the 
measurement was conducted, due to improvement of their psychiatric condition. After 
applying the in- and exclusion criteria and adding the pilot data, the study sample 
comprised 50 patients. Figure 1 shows the flowchart of the study. 
 
 Procedure 
 Every new patient who was hospitalized during the time of the data-collection 
and who met the inclusion criteria was approached to participate in the study. The 
patients were informed about the study by the researcher or research assistant. When a 
patient agreed to participate, an appointment was scheduled to complete the 
measurement. At the start of the appointment, the patients were asked to sign an 
informed consent form. The measurements were conducted by either the researcher or 
research assistant, and took approximately 45 minutes to complete. The measurements 
were conducted in consulting and testing rooms at Parnassia. The Medical Ethics 
Committee of Leiden University Medical Centre (LUMC) issued a declaration of no 
objection for this study. 
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Figure 1. Flowchart of the selection process.  
 
Measures  
 Frailty was assessed by the five criteria of Fried et al. (2001), operationalized 
as follows:  
The Short Nutritional Assessment Questionnaire (SNAQ) assessed weight loss 
(Kruizenga, Seidell, de Vet, Wierdsma, & van Bokhorst- de van der Schueren, 2005). 
If a patient lost 4.5 kilograms or more in the previous year, this criterion was 
considered present.  
A handgrip meter that measured muscle strength assessed weakness. Gender 
and age-specific cut-off scores were used to evaluate the scores (Mathiowetz et al., 
1985). If a patient scored lower than the mean score of the norm group, according to 
the Mathiowetz et al. (1985) cut-off scores, this criterion was considered present.  
Total hospitalized 
patients 
(n = 74) 
Patients selected based 
on inclusion criteria 
(n = 64) 
 
Patients after applying 
exclusion criteria 
(n = 47) 
 
Patients selected 
(n = 38) 
 
Total study sample 
(including pilot data) 
(n = 50) 
 
Patients not meeting inclusion 
criteria 
(n = 10) 
- <65 years (n = 10) 
Patients excluded 
(n = 17) 
- Non-fluent Dutch (n = 1) 
- Dementia diagnosis (n = 11) 
- Refused participation (n = 5) 
Patients excluded for 
other reasons (n = 9) 
-Discharge (n = 6) 
-Untestable (n = 3) 
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Two items of the Center for Epidemiologic Studies Depression Scale (CES-D) 
assessed exhaustion (Radloff, 1977; Dutch translation: Bouma, Ranchor, Sanderman, 
& van Sonderen, 1995). If the patient scored high, that is a score of 2 (regularly 
present) or 3 (mostly or always present) on both of these items, this criterion was 
considered present. 
Walking speed measured slowed gait. Patients were asked to walk 4 meters, 
with walking aid if necessary. Cut-off scores from the Fried et al. (2001) study were 
used to evaluate walking speed. If walking speed of a patient was slower than the 
mean walking speed of the norm group, according to the Fried et al. (2001) cut-off 
scores, or if it was not possible to walk at all, this criterion was considered present.  
Three items of the Netherlands Study of Depression in Older Persons (NESDO 
study), a study on late-life depression and its course and co-morbidities, assessed low 
physical activity (Comijs et al., 2011). If the patient scored a total of 0 on these items 
(no physical activity of any kind), this criterion was considered present.  
According to Fried et al. (2001) if three or more of the five criteria were 
present, a patient was considered frail. In the statistical analyses frailty was evaluated 
as a dichotomous variable.  
The MMSE (Folstein, Folstein, & McHugh,1975; Dutch translation: Kok & 
Verhey, 2002) and the clock drawing test (Manos & Wu, 1994) assessed cognitive 
functioning. Both the MMSE (Folstein et al., 1975) and the clock drawing test (Agrell 
& Dehlin, 1998) are useful screening tests to detect cognitive dysfunction. The clock 
drawing test is most commonly used as an additional screener to the MMSE (Smits, 
Koene, Pijnenburg, Scheltens, & van der Flier, 2009). A lower score on both the 
MMSE (range 0-30) and the clock drawing test (range 0-10) indicates worse cognitive 
performance. Both scores were combined to measure cognitive impairment. Cut-off 
points were set at ≤24 for the MMSE (Folstein et al., 1975) and ≤7 for the clock 
drawing test (Manos, 2006). If the patient scored ≤24 on the MMSE and ≤7 on the 
clock drawing test, cognitive impairment was considered present. In the statistical 
analyses, cognitive impairment was evaluated as a dichotomous variable.  
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Statistical analyses  
Descriptive analyses were used to study the prevalence of frailty and the 
prevalence of the co-occurrence of frailty and cognitive impairment, answering 
research question 1.1 and 2.1. Chi-squared (χ²) tests were performed to test the gender 
and DSM-5 diagnosis differences, answering research question 1.2 and 1.3. In the χ² 
tests frailty and gender were dichotomous variables and DSM-5 diagnosis categorical. 
DSM-5 diagnoses have been categorized in three diagnosis groups: depressive 
disorders, bipolar disorders, and psychotic disorders, as these three diagnosis groups 
are most common at this old age department.   
 Logistic regression was performed to examine the association between frailty 
and cognitive impairment, answering research question 2.2. In this regression 
cognitive impairment (dichotomous) was the independent variable and frailty 
(dichotomous) the dependent variable. Logistic regression was also performed to 
examine the association between weakness/slowness and cognitive impairment, 
answering research question 2.3 and 2.4. In these regression analyses weakness and 
slowness (both dichotomous) were the dependent variables and cognitive impairment 
(dichotomous) the independent variable. All three logistic regression analyses were 
performed stepwise; first without, and second with covariates age and gender. In this 
study, we were interested in the adjusted results, the unadjusted results have been 
added for sensitivity analyses.  
To perform the statistical analyses IBM SPSS statistics version 23 was used. 
The significance threshold was set on p = .05.  
Both assumptions for the Chi-squared tests (independence of data and 
expected frequencies) were met. Two assumption for the logistic regressions 
(independence of errors and multicollinearity) were also met, the assumption of 
linearity did not apply to our data. Independence of errors was checked with the 
Durbin-Watson. Multicollinearity was checked with tolerance and VIF statistics. 
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Results 
 
Prevalence 
The study sample comprised 50 patients, of which 20.0% were male. The 
average age of the sample was 74.9 years (SD = 7.1). Table 1 shows the 
characteristics of the sample. A total of 18 patients were considered to be frail, 
meaning that the prevalence of frailty in this sample was 36.0%. We found no 
significant gender differences in the prevalence of frailty (χ²(1) = 1.389 p = .239). 
There was also no significant difference in frailty prevalence between the DSM-5 
diagnosis groups ( χ²(2) = 0.820 p = .664). A total of 8 patients were considered to be 
both frail and cognitively impaired, meaning that the prevalence of the co-occurrence 
of frailty and cognitive impairment was 16.7% in this sample.  
 
Table 1. Baseline characteristics  
 Total 
n = 50 
Frail 
n = 18 
Non frail 
n = 32 
Gender, n (%)  
 Female  
 
40 (80.0%) 
 
16 (88.9%) 
 
24 (75.0%) 
 Male 10 (20.0%) 2 (11.1%) 8 (25.0%) 
Age, M (SD) 74.9 (7.1) 75.3 (7.4) 74.6 (7.0) 
MMSE, M (SD) 24.6 (4.2) 23.3 (3.2) 25.3 (4.5) 
Clock drawing test, M (SD) 6.1 (3.4) 4.3 (3.7) 7.1 (2.9) 
Cognitive impairment, n (%) 14 (28.0%) 8 (44.4%) 6 (18.8%) 
Weight loss, n (%) 22 (44.0%) 13 (72.2%) 9 (28.1%) 
Weakness, n (%) 29 (58.0%) 17 (94.4%) 12 (37.5%) 
Exhaustion, n (%) 24 (48.0%) 17 (94.4%) 7 (21.9%) 
Slowness, n (%) 15 (30.0%) 12 (66.7%) 3 (9.4%) 
Physical inactivity n (%) 5 (10.0%) 5 (27.8%) 0 (0.0%) 
DSM-5 diagnosis n (%)    
 Depressive disorder  24 (48.0%) 10 (55.6%) 14 (43.8%) 
 Bipolar disorder  9 (18.0%) 4 (22.2%) 5 (15.6%) 
 Psychotic disorder  14 (28.0%) 4 (22.2%) 10 (31.3%) 
Note. MMSE = Mini Mental State Examination, DSM = Diagnostic and Statistical 
Manual of Mental Disorders 
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Association frailty and cognitive impairment 
Cognitive impairment was found to be a significant predictor of frailty. Table 
2 shows the unadjusted and adjusted associations between frailty and cognitive 
impairment. Cognitively impaired patients were, after adjusting for age and gender, 
over 5 times more likely to be frail than cognitively intact patients. Cognitive 
impairment was also a significant predictor of the frailty component weakness. 
Cognitively impaired patients were, after adjusting for age and gender, almost 9 times 
more likely to have low muscle strength than cognitively intact patients. Cognitive 
impairment was also a significant predictor of the frailty component slowness. 
Cognitively impaired patients were, after adjusting for age and gender, almost 7 times 
more likely to have slow walking speed than cognitively intact patients.  
 
Table 2. logistic regression with cognitive impairment as predictor of frailty 
  Unadjusted Adjusted* 
  B [SE] OR [95% CI] p B [SE] OR [95% CI] p 
frailty 1.47 [0.68] 4.33 [1.16-16.26] .030 1.73 [0.74] 5.45 [1.33-23.94] .019 
weakness 2.02 [0.84] 7.60 [1.47-39.29] .016 2.19 [0.87] 8.89 [1.62-48.86] .012 
slowness 1.35 [0.68] 3.86 [1.01-14.69] .048 1.92 [0.83] 6.81 [1.35-34.38] .020 
* adjusted for age and gender     
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Discussion 
 
The first aim of this study was to describe the prevalence of frailty, and gender 
and DSM-5 differences in this prevalence. The second aim was to examine the 
relationship between frailty and cognitive impairment in our sample of elderly with 
psychiatric disorders. Frailty was assessed with the five Fried et al. (2001) criteria 
(unintentional weight loss, weakness, exhaustion, slowed gait, and low physical 
activity level) and cognitive functioning was assessed with the MMSE and clock 
drawing test. We found both a high prevalence of frailty and a high prevalence of the 
co-occurrence of frailty and cognitive impairment. Furthermore, we found a strong 
association between cognitive impairment and frailty, and between cognitive 
impairment and two of the frailty components. Examining frailty and the relationship 
between frailty and cognitive impairment in this group of elderly is important because 
it could lead to evidence-based interventions, which in turn could lead to a reduction 
in healthcare costs (Butler et al., 2016; Collard & Oude Voshaar, 2012).  
 The prevalence of frailty was 36.0% in this study, which is much higher than 
the frailty prevalence of 6.9% found in community dwelling elderly (Fried et al. 
2001). This suggests that frailty may be more prevalent in elderly with psychiatric 
disorders than in elderly without psychiatric disorders. One possible explanation for 
this could be the overlap between frailty and psychiatric disorders (Collard & Oude 
Voshaar, 2012). Depression, for example, shares risk factors (e.g., low grade 
inflammation), common symptoms (e.g., exhaustion), and adverse health outcomes 
(e.g., mortality) with frailty (Buigues et al., 2014). However, the overlap between 
frailty and psychiatric disorders in general remains unclear, and should be further 
investigated in future research. Another possible explanation, at least in part, for the 
high frailty prevalence we found, compared to that of Fried et al. (2001), is the higher 
proportion (80.0%) of female participants in our sample, as opposed to the 57.9% of 
Fried et al. (2001). However, we found no significant gender differences in the 
prevalence of frailty in our sample. This is not in line with our hypothesis or with 
previous research, as the majority of existing frailty studies found a significantly 
higher prevalence in women compared to men (Fried et al., 2001; Rockwood et al., 
2004). One possible explanation for not finding a significant gender difference in our 
sample could be the small sample size, which could have led to type II error. We also 
found no significant differences in the prevalence of frailty between the three DSM-5 
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diagnosis groups (depressive disorders, bipolar disorders, and psychotic disorders). 
This could indicate that the type of DSM-5 diagnosis does not influence the chance of 
being frail. Hypothetically, considering the high frailty prevalence in our sample, it 
could indicate an underlying vulnerability of having a psychiatric conditioning in 
itself that causes a higher chance to be frail, instead of one type of DSM-5 diagnosis 
being at higher risk. However, it is also possible that the nonsignificant result was a 
consequence of the small sample size, which could have led to type II error. More 
research is needed to investigate these possibilities, as potential differences in frailty 
per DSM-5 diagnosis could be important to offer different patient groups appropriate 
treatment.  
We found a prevalence of the co-occurrence of frailty and cognitive impairment of 
20.8%. This combined prevalence is much higher than the 2.7% found by Shimada et 
al. (2013) in a Japanese sample of community dwelling elderly. This result could be 
explained by the high frailty prevalence we found in our sample, 36.0% compared to 
11.3% found by Shimada et al. (2013). Hypothetically, another explanation could be 
that elderly with psychiatric disorders are in fact more likely to be both frail and 
cognitively impaired than non-psychiatric elderly, which in turn could be explained 
by the fact that cognitive impairment is more common in patients with psychiatric 
disorders, e.g., bipolar disorder (Coffman, Bornstein, Olson, Schwarzkopf, & 
Nasrallah, 1990) and schizophrenia (Taylor and Abrams, 1984). However, future 
research should point out whether there are significant differences between non-
psychiatric and psychiatric elderly patients in this combined prevalence, as potential 
differences between these groups could be important in the diagnostic and treatment 
phases.  
 Cognitive impairment was found to be a significant predictor of frailty in our 
sample, which is in line with our hypothesis and previous research (Jacobs et al., 
2011; Han et al., 2014). The cognitively impaired patients in our sample were over 
five times more likely to be frail than cognitively intact patients. This relationship 
between cognitive impairment and frailty could possibly be explained by the shared 
underlying mechanisms, e.g., neuropathological mechanisms, chronic inflammation, 
hormonal mechanisms, cardiovascular disease, and nutrition (Buchman et al., 2008; 
Kang et al., 2016; Robertson et al., 2013). It seems that having a psychiatric condition 
is causing the relationship between cognitive impairment and frailty to be even 
stronger, as we found a higher OR in our sample than Han et al. (2014) in their sample 
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of non-psychiatric elderly. They found that cognitively impaired participants were 
twice as likely to be frail than cognitively intact participants. This assumption is in 
line with the findings of Robertson et al. (2013), who found that mood disorders have 
an amplifying influence on the relationship between frailty and cognitive impairment. 
However, the high odds ratio could also be caused by the high frailty prevalence we 
found in our study. Cognitive impairment was also a significant predictor of 
weakness, one of the frailty components, in our sample, which is in line with our 
hypothesis and previous research (Alvaro-Acha et al., 2006; Houles et al., 2012). The 
cognitively impaired patients in our sample were almost nine times more likely to 
have low muscle strength than cognitively intact patients. A possible explanation for 
this relationship could be that loss of muscle strength and cognitive decline share the 
same underlying mechanisms (e.g., chronic inflammation), causing a general decline 
in brain structure and function (Alfaro-Acha et al., 2006). Cognitive impairment was 
also a significant predictor of slowness, one of the frailty components, in our sample, 
which is in line with our hypothesis and previous research (Abellan van Kan et al., 
2009; Houles et al., 2012). The cognitively impaired patients in our sample were 
almost seven times more likely to have slow walking speed than cognitively intact 
patients. A possible explanation for this relationship could be that in order to walk, 
several cognitive functions (e.g., attention, executive functioning, visuospatial 
functioning) are needed, thus slow gait speed and cognitive impairment may also 
share the same underlying mechanisms (Buracchino, Dodge, Howieson, Wasserman, 
& Kaye, 2010). Considering these results, it is possible that of all frailty components, 
weakness and slowed gait show the strongest relation with cognitive impairment, 
which is in line with previous research (Buchman et al. 2014; Robertson et al., 2014). 
However, future research should investigate which of all five frailty components show 
the strongest relation with cognitive impairment in psychiatric elderly patients.  
 Strengths of our study are the high participation rate, implying our sample 
should be an adequate representation of the elderly psychiatric inpatient population. 
Furthermore, we used valid and reliable measures, e.g., the five Fried et al. (2001) 
criteria which are used by over 300 other studies. This makes our study easily 
comparable to other studies on the topic. Despite the strengths of this study, there are 
some limitations that should be considered when interpreting the findings. First, 
because of our cross-sectional study design, we cannot show a causal relationship 
between frailty and cognitive impairment in our sample. Previous longitudinal 
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research has shown an interrelationship between frailty and cognitive impairment in 
community dwelling elderly (Ávila-Funes et al., 2012; Samper-Ternent et al., 2008; 
Solfrizzi et al., 2013), and multiple possible underlying mechanisms have been 
suggested to explain this interrelationship. However, future longitudinal research 
should indicate whether this interrelationship also exists in elderly with psychiatric 
disorders. Second, our sample size of 50 patients was small, which may have led to 
type II error. The small sample size could also be an explanation for the wide 95% 
confidence intervals in the regression analyses. Also, our study sample comprised 
more women than men, which could have caused bias. However, in the psychiatric 
hospital where the current study was conducted, it is the standard that more women 
are hospitalized than men. Thus, the skewed gender distribution of our sample should 
actually be an adequate representation of their inpatient population. This is in line 
with the existing literature about gender differences in psychiatric disorders, as for 
example mood disorders, which are highly present in this psychiatric hospital, have 
been found to be more prevalent in women compared to men (ten Have, Schoemaker, 
& Volleberg, 2002; Nolen-Hoeksema, 1987). The third limitation to our study was 
that we only included inpatients which may have led to selection bias, as it is possible 
that frail patients get hospitalized more than non-frail patients. The fourth limitation 
of our study is that cognitive functioning has been measured by only two screening 
instruments. Ideally, a complete neuropsychological test-battery should assess 
cognitive functioning, as a neuropsychological test-battery will give a more valid 
representation of cognitive functioning and it will allow investigating the different 
domains of cognition.  
 In conclusion, this study investigated frailty and the relationship between 
frailty and cognitive impairment in elderly with psychiatric disorders, which has 
received little attention in the existing literature. The current study contributes and 
adds to the knowledge on this topic. We found that both frailty and the co-occurrence 
of frailty and cognitive impairment are highly prevalent in elderly with psychiatric 
disorders (36.0% and 20.8%, respectively). Additionally, cognitive impairment 
predicted frailty, and particularly the two frailty components grip strength and 
walking speed. Therapists should be aware of the higher chance of a cognitively 
impaired patient to also be frail. When aware of this, therapists can take precautionary 
actions and commence intervention. Future research, especially longitudinal, is 
needed to examine the interrelationship between frailty and cognitive impairment, the 
18 
 
underlying mechanisms (e.g., cardiovascular disease, nutrition), the different domains 
of cognition and the possible interventions (e.g., special diet, physiotherapy) in this 
population of patients with psychiatric disorders. Also, future research should include 
psychiatric patients who are not hospitalized but receive outpatient treatment for their 
psychiatric condition. This could lead to a more adequate representation of the total 
population of elderly with psychiatric disorders, and in turn lead to more generalizable 
conclusions.  
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